Original Articles
Rapid antigen tests for SARS-CoV-2
Michael Liu, Rahul K. Arora and Mel Krajden
CMAJ March 02, 2021 cmaj.202827; DOI: https://doi.org/10.1503/cmaj.202827
Michael Liu
Harvard Medical School (Liu), Boston, Mass.; Unity Health Toronto (Liu), St. Michael’s Hospital, Toronto, Ont.; Institute of Biomedical Engineering (Arora), University of Oxford, Oxford, UK; Department of Community Health Sciences (Arora), University of Calgary, Calgary, Alta.; Department of Pathology and Laboratory Medicine (Krajden), University of British Columbia; BC Centre for Disease Control (Krajden), Vancouver, BC.
Rahul K. Arora
Harvard Medical School (Liu), Boston, Mass.; Unity Health Toronto (Liu), St. Michael’s Hospital, Toronto, Ont.; Institute of Biomedical Engineering (Arora), University of Oxford, Oxford, UK; Department of Community Health Sciences (Arora), University of Calgary, Calgary, Alta.; Department of Pathology and Laboratory Medicine (Krajden), University of British Columbia; BC Centre for Disease Control (Krajden), Vancouver, BC.
Mel Krajden
Harvard Medical School (Liu), Boston, Mass.; Unity Health Toronto (Liu), St. Michael’s Hospital, Toronto, Ont.; Institute of Biomedical Engineering (Arora), University of Oxford, Oxford, UK; Department of Community Health Sciences (Arora), University of Calgary, Calgary, Alta.; Department of Pathology and Laboratory Medicine (Krajden), University of British Columbia; BC Centre for Disease Control (Krajden), Vancouver, BC.
In this issue
Article tools
Rapid antigen tests for SARS-CoV-2
Michael Liu, Rahul K. Arora, Mel Krajden
CMAJ Mar 2021, cmaj.202827; DOI: 10.1503/cmaj.202827